Crewe Advisors LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 7.9% in the second quarter, HoldingsChannel reports. The institutional investor owned 371 shares of the medical equipment provider’s stock after selling 32 shares during the quarter. Crewe Advisors LLC’s holdings in Intuitive Surgical were worth $165,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Creekmur Asset Management LLC lifted its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the 2nd quarter worth $26,000. Able Wealth Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $28,000. Delos Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the period. Finally, MeadowBrook Investment Advisors LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $30,000. 83.64% of the stock is owned by institutional investors.
Intuitive Surgical Stock Up 1.1 %
ISRG traded up $5.46 during trading hours on Friday, hitting $492.63. 1,097,672 shares of the company’s stock were exchanged, compared to its average volume of 1,521,578. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $493.97. The stock’s 50-day moving average is $453.49 and its two-hundred day moving average is $413.69. The stock has a market cap of $174.74 billion, a price-to-earnings ratio of 88.92, a PEG ratio of 4.97 and a beta of 1.39.
Insider Transactions at Intuitive Surgical
In other news, Director Craig H. Barratt sold 2,496 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $402.89, for a total transaction of $1,005,613.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Craig H. Barratt sold 2,496 shares of the business’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 239 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $416.60, for a total value of $99,567.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,293,799.60. The disclosure for this sale can be found here. In the last three months, insiders sold 55,552 shares of company stock worth $26,281,657. 0.90% of the stock is owned by company insiders.
Analyst Ratings Changes
Several brokerages have recently issued reports on ISRG. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Robert W. Baird lifted their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. The Goldman Sachs Group began coverage on Intuitive Surgical in a research report on Thursday, May 30th. They issued a “buy” rating and a $500.00 price target on the stock. Morgan Stanley upped their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. Finally, Barclays raised their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $446.45.
Get Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Dividend Capture Strategy: What You Need to Know
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- What is Short Interest? How to Use It
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- What is Insider Trading? What You Can Learn from Insider Trading
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.